Category: Pipeline
PharmaSignal — Pipeline
Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine
April 21, 2026
BioPharma Dive
The startup is developing modified DNA therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway
April 8, 2026
BioSpace
After a Phase 2 flop, Brinsupri exits the race to market for the chronic skin disease hidradenitis suppurativa, but other companies, including Incyte, Novartis and UCB, have recently notched clinical
Pharma Pipeline Stalls for First Time in Decades: Citeline
April 6, 2026
BioSpace
Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an upward trend in investigational assets.
How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup
March 24, 2026
BioPharma Dive
Cohen says he looked at around two dozen companies since Acorda wound down.